Director of Ionis Pharmaceuticals Inc (NASDAQ:IONS), Parshall B Lynne, sells 710 shares worth $36,082
According to Ionis Pharmaceuticals Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 06:56 PM, company Director, Parshall B Lynne disclosed selling 710 shares at a cost of $50.82. At the time of this transaction (Nov 24), this trade was worth $36,082 in total. As of Nov 24, Parshall B Lynne now owns 67,464 shares in total worth about $3,389,391.3600000003.
For the last few recent trades made by Ionis Pharmaceuticals Inc (NASDAQ:IONS) Director, Parshall B Lynne, we have the following information:
- SEC Form 4 filing: Nov 23: Sold 3,200 shares at the rate of $50.12 per share. Total worth of this trade was $160,384. Total number of shares owned as of Nov 23 were 67,464
- SEC Form 4 filing: Apr 29: Sold 50,000 shares at the rate of $75.01 per share. Total worth of this trade was $3,750,635. Total number of shares owned as of Apr 29 were 52,677
- SEC Form 4 filing: Mar 12: Sold 8,334 shares at the rate of $75.00 per share. Total worth of this trade was $625,050. Total number of shares owned as of Mar 12 were 52,677
Posted by
George Daniels
on Thursday November 26 2020, 1:53 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
